Capsule Summaries

Share

Program Content

Activities

  • ANRS 12300 Reflate TB2
    ANRS 12300 Reflate TB2: RAL + 3TC/TDF Does Not Achieve Noninferior Efficacy vs EFV + 3TC/TDF at Wk 48 in ART-Naive Adults With HIV and TB
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 23, 2019

  • GEMINI
    GEMINI-1 and -2: DTG + 3TC Noninferior to DTG + FTC/TDF at Wk 96 in ART-Naive Adults
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 24, 2019

  • BRIGHTE
    BRIGHTE: Wk 96 Results From Phase III Study of Fostemsavir + OBT in Heavily Treatment–Experienced Patients Failing Current ART
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 24, 2019

  • Tsepamo
    Tsepamo: DTG Exposure at Conception Associated With Smaller Increase in Incidence of Neural Tube Defects in Updated Analysis
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 24, 2019

  • ATLAS: PROs With LA-ART
    ATLAS: Patient-Reported Outcomes From Phase III Study of Switch to Long-Acting Injectable Cabotegravir + Rilpivirine in Virologically Suppressed Patients
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 25, 2019

  • DISCOVER: TFV-DP Levels
    DISCOVER: More Rapid and Sustained Protective Levels of TFV-DP With FTC/TAF vs FTC/TDF as PrEP
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 26, 2019

  • Switch to BIC/FTC/TAF
    Study 380-4030: Switch to BIC/FTC/TAF Noninferior to DTG + FTC/TAF in Virologically Suppressed Adults
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 26, 2019

  • TANGO
    TANGO: Switch to DTG/3TC Noninferior to Continued TAF-Based ART in Virologically Suppressed Adults
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 26, 2019

  • Islatravir + Doravirine
    DRIVE2Simplify, Part 2: Wk 48 Results From Phase IIb study of Islatravir + Doravirine vs DOR/3TC/TDF in ART-Naive Adults
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 29, 2019

  • ADVANCE
    ADVANCE: DTG + FTC/(TAF or TDF) Noninferior to EFV/FTC/TDF in ART-Naive Patients in South Africa
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 29, 2019

Provided by

ProCE Banner

Supporters

Gilead

ViiV Healthcare

Partners

IAS 2018

ProCE Banner

IAS 2019

ProCE Banner